New Study Examines Biomarkers of Hereditary Angioedema not Caused by C1-INH
source: pixabay.com

New Study Examines Biomarkers of Hereditary Angioedema not Caused by C1-INH

Hereditary Angioedema Hereditary angioedema (HAE) is a rare disease which causes swelling episodes throughout the body, including the airways, gastrointestinal system, and extremities. Most commonly, HAE is caused by a…

Continue Reading New Study Examines Biomarkers of Hereditary Angioedema not Caused by C1-INH
ICYMI: Company Announces Halt of Fibrodysplasia Ossificans Progressiva Clinical Development Program
source: pixabay.com

ICYMI: Company Announces Halt of Fibrodysplasia Ossificans Progressiva Clinical Development Program

According to a story from newswiretoday.com, the biopharmaceutical group Ipsen has recently announced its decision to halt its dosing of patients in its phase 3 clinical trial and its phase…

Continue Reading ICYMI: Company Announces Halt of Fibrodysplasia Ossificans Progressiva Clinical Development Program
One Fibrodysplasia Ossificans Progressiva Trial is on Hold but Another has Shown Promise
source: pixabay.com

One Fibrodysplasia Ossificans Progressiva Trial is on Hold but Another has Shown Promise

Ipsen is a pharmaceutical company based out of Paris. Sadly, they have just announced that they have pressed pause on not one but two studies for fibrodysplasia ossificans progressiva (FOP). FOP…

Continue Reading One Fibrodysplasia Ossificans Progressiva Trial is on Hold but Another has Shown Promise
Phase 2b Trial for Mitochondrial Diseases has Begun
source: pixabay.com

Phase 2b Trial for Mitochondrial Diseases has Begun

Khondrion has just announced that the very first patient has been dosed in their Phase 2b study for mitochondrial diseases called KHENERGYZE. This patient population has a high unmet need…

Continue Reading Phase 2b Trial for Mitochondrial Diseases has Begun
Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
source: pixabay.com

Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment

FightMND is an Australian nonprofit organization dedicated to improving the lives of motor neurone disease patients through funding research for cures. They've successfully provided millions toward research initiatives and clinical…

Continue Reading Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling
source: pixabay.com

A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling

The Platform Notable's automated technology platform was created to help predict which patients would respond better to which therapies. As no patient is the same, this study is paramount. Notable…

Continue Reading A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling
Searching for the Cause of Lung Disease in Systemic Juvenile Idiopathic Arthritis
source: pixabay.com

Searching for the Cause of Lung Disease in Systemic Juvenile Idiopathic Arthritis

  According to a recent article in MedPage Today’s 2019 year-end review, the number of life-threatening lung diseases in systemic juvenile idiopathic arthritis (sJIA) patients has been increasing. sJIA is…

Continue Reading Searching for the Cause of Lung Disease in Systemic Juvenile Idiopathic Arthritis
Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss
source: pixabay.com

Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss

According to a story from Medical Xpress, a team of researchers from the medical school at the University of Massachusetts has revealed new information about the nature of neurodegenerative symptoms…

Continue Reading Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss
A New University of Alabama Study Finds That Norepinephrine is the Missing Piece in the Alzheimer’s Puzzle
source: pixabay.com

A New University of Alabama Study Finds That Norepinephrine is the Missing Piece in the Alzheimer’s Puzzle

  It has been evident to scientists for years that Alzheimer’s disease, which affects about five million people in the U.S., is caused by an accumulation of two proteins within…

Continue Reading A New University of Alabama Study Finds That Norepinephrine is the Missing Piece in the Alzheimer’s Puzzle
New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future
source: pixabay.com

New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future

According to a story from Newswise, a team of scientists and researchers associated with Université de Montréal and CHU Sainte-Justine have recently completed a study that maps a cellular model…

Continue Reading New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future